WILMINGTON, Mass., Jan. 6, 2014 /PRNewswire/ -- Implant Sciences Corporation (OTCQB:IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, announced today that The Manufacturing Institute will award Implant Sciences' Vice President, Manufacturing and Technical Services, Brenda Baron, with the Women in Manufacturing STEP (Science, Technology, Engineering, and Production) Award. The STEP Awards honor women who have demonstrated excellence and leadership in their careers and represent all levels of the manufacturing industry, from the factory-floor to the C suite.
Implant Sciences' Vice President of Manufacturing and Technical Services, Brenda Baron stated, "I am honored to receive this award and to be included alongside the other recipients, who are truly the leading women in American manufacturing. I am proud to be part of the team at Implant Sciences, which has given me every opportunity to thrive professionally and grow the manufacturing organization from the ground up. Driven by a passion for excellence, our entire organization is focused on quality and cost effectiveness, with a deep commitment to keeping manufacturing in the United States."
"Brenda has driven a culture of operational excellence at Implant Sciences. We are fortunate to have her as one of our key executives and pleased that she is being honored by the 2014 STEP Awards," stated Implant Sciences' President and CEO, Glenn D. Bolduc. "She established the complete manufacturing and services organization for Implant Sciences, which now rivals that of its very large competitors while maintaining a small company, entrepreneurial environment, and keeping customer service at the forefront."
"These 160 women are the faces of exciting careers in manufacturing," said Jennifer McNelly, President of The Manufacturing Institute. "We chose to honor these women because they each made significant achievements in manufacturing through positive impact on their company and the industry as a whole. The STEP Awards are part of the larger STEP Ahead initiative, launched to examine and promote the role of women in the manufacturing industry through recognition, research, and leadership for attracting, advancing, and retaining strong female talent.
On February 6, The Manufacturing Institute will recognize 160 recipients of the STEP Awards at a reception in Washington, D.C. The STEP Awards program will highlight each Honoree's story, including their leadership and accomplishments in manufacturing.
About Implant Sciences
Implant Sciences is the leader in next generation Explosives Trace Detection (ETD) technology. In January 2013, the Company became only the third ETD manufacturer, and the sole American-owned company, to have product approval from the US Transportation Security Administration. Implant Sciences has developed proprietary technologies used in its commercial explosives and drugs trace detection systems, which ship to a growing number of locations domestically and internationally. Implant Sciences' QS-H150 portable explosives trace detector has received Qualified Anti-Terrorism Technology Designation and, in addition to receiving TSA qualification for air cargo screening, the Company's QS-B220 has also received STAC certification, a Developmental Testing & Evaluation (DT&E) Designation by the U.S. Department of Homeland Security under the Support Anti-terrorism by Fostering Effective Technology Act of 2002 (the SAFETY Act), and the GSN 2013 Homeland Security Award for "Best Explosives Detection Solution". For further details on the Company and its products, please visit the Company's website at http://www.implantsciences.com.
About The Manufacturing Institute
The Manufacturing Institute (the Institute) is the 501(c)(3) affiliate of the National Association of Manufacturers. As a non-partisan organization, the Institute is committed to delivering leading-edge information and services to the nation's manufacturers. The Institute is the authority on the attraction, qualification, and development of world-class manufacturing talent. For more information, please visit www.themanufacturinginstitute.org.
Safe Harbor Statement
This press release may contain certain "forward-looking statements," as that term is defined in the Private Securities Litigation Reform Act of 1995. Such statements are based on management's current expectations and are subject to risks and uncertainties that could cause the Company's actual results to differ materially from the forward-looking statements. Such risks and uncertainties include, but are not limited to, the risks that we will be required to repay all of our indebtedness to our secured lender, DMRJ Group, by March 31, 2014; if we are unable to satisfy our obligations to DMRJ and to raise additional capital to fund operations, DMRJ may seize our assets and our business may fail; we continue to incur substantial operating losses and may never be profitable; our independent registered public accounting firm has expressed substantial doubt as to our ability to continue as a going concern; our explosives detection products and technologies (including any new products we may develop) may not be accepted by the Transportation Security Administration or by other U.S. or foreign government and law enforcement agencies or commercial consumers of security products; economic, political and other risks associated with international sales and operations could adversely affect our sales; the risk that liability claims related to our products or our handling of hazardous materials could damage our reputation and have a material adverse effect on our financial results; the risk that our business is subject to intense competition; the risks that our markets are subject to rapid technology change and that our success depends on our ability to develop and introduce new products; the risks that we may not be able to retain our management and key employees or to identify, hire and retain additional personnel as needed; the risks that we may not be able to enforce our patent and other intellectual property rights or operate without infringing on the proprietary rights of others: and other risks and uncertainties described in our filings with the Securities and Exchange Commission, including its most recent Forms 10-K, 10-Q and 8-K. Such statements are based on management's current expectations and assumptions which could differ materially from the forward-looking statements.
For further information, you are encouraged to review Implant Sciences' filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K for the period ended June 30, 2013. The Company assumes no obligation to update the information contained in this press release.
Implant Sciences Corporation
Glenn Bolduc, CEO
SOURCE Implant Sciences Corporation